CA Patent

CA2952406A1 — Solid formulation and method for preventing or reducing coloration thereof

Assigned to Elobix AB · Expires 2015-12-30 · 10y expired

What this patent protects

The present invention pertains to stabilization of a certain class of benzothia(dia)zepine derivative, in a solid preparation containing the derivative. According to the present invention, either the solid preparation containing the benzothia(dia)zepine derivative does not incorp…

USPTO Abstract

The present invention pertains to stabilization of a certain class of benzothia(dia)zepine derivative, in a solid preparation containing the derivative. According to the present invention, either the solid preparation containing the benzothia(dia)zepine derivative does not incorporate a combination of polyethylene glycol and polyvinyl alcohol; or, in the case that the solid preparation does incorporate a combination of polyethylene glycol and polyvinyl alcohol, the derivative and the combination of polyethylene glycol and polyvinyl alcohol are isolated.

Drugs covered by this patent

Patent Metadata

Patent number
CA2952406A1
Jurisdiction
CA
Classification
—
Expires
2015-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Elobix AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.